Richardson Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Richardson Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-79	Closed	-$1.57K	–	397
2026 Q1	$1.57K	Buy	+79	New	+$1.86K	﹤0.01%	367

Other funds holding KMTS

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Richardson Capital Management's KMTS Position: Q2 2026 in Review

Richardson Capital Management sold out of Kestra Medical Technologies (KMTS) in Q2 2026, closing a stake of 79 shares — an estimated $1.57K sold.

Richardson Capital Management first reported a position in KMTS in Q1 2026 and held it in 1 quarter. The position peaked at $1.57K in Q1 2026. 3 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

Richardson Capital Management reported no remaining Kestra Medical Technologies position as of Q2 2026 after selling out during the quarter.
Richardson Capital Management sold 79 Kestra Medical Technologies shares in Q2 2026, an estimated $1.57K.
Richardson Capital Management first reported a position in Kestra Medical Technologies in Q1 2026 and held it in 1 quarter.
Richardson Capital Management's Kestra Medical Technologies position peaked at $1.57K in Q1 2026.
3 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Richardson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.